PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers Perspective
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.991
https://www.valueinhealthjournal.com/article/S1098-3015(11)02553-8/fulltext
Section Title :
Systemic Disorders/Conditions
Section Order :
949
First Page :
A413
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02553-8&doi=10.1016/j.jval.2011.08.991